Telix Pharmaceuticals (TLX) Stock Price, Quote, News & History | Benzinga

Comments

Telix Pharmaceuticals Ltd (TLX) Stock Price, Quote, News & History

TLXNASDAQ

Trade with Public

Trade with Public

$6.53

0.101.56%

Last update: Feb 13, 10:59 AM

OverviewNews Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$6.44

Close

-

Volume / Avg.

67.00K / 164.47K

Day Range

$6.34 - $6.57

52 Wk Range

6.40 - 30.36

Market Cap

$2.19B

P/E Ratio

275.78

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

0.04%

Days to Cover

1

Recent Telix Pharmaceuticals Ltd News

Telix Pharmaceuticals Reports Strong Full-Year Revenue, But Shares Remain Under Pressure

Telix Pharmaceuticals meets its FY25 revenue target with strong Q4 growth, expanded U.S. launches and ongoing trials.

Vandana Singh

Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance

Telix Pharmaceuticals posts 53% Q3 revenue growth to $206 million, lifts FY25 guidance to up to $820 million amid strong PSMA imaging and reimbursement gains.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-

Investing Cash Flow (TTM)

-312.48M

Financing Cash Flow (TTM)

392.96M

Free Cash Flow (TTM)

-13.00M

Capital Expenditure (TTM)

-34.17M

Net Change in Cash (TTM)

101.65M

Analyst Trends and Forecast

1

1

Aug 25

3

Sep 25

1

Dec 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.49B

PE Ratio (TTM)

275.78

PE Ratio (FWD)

54.95

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.53

PB Ratio (TTM)

5.10

Earnings Yield % (TTM)

0.36%

Earnings Yield % (FWD)

1.82%

EV / EBITDA (TTM)

57.06

Price / EBITDA (TTM)

54.02

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.26

Company Debt

Total Debt

$384.17M

LT Debt

$371.48M

LT Debt Issuance (TTM)

$406.09M

LT Debt Repayment (TTM)

-$4.76M

Total Cash

$207.16M

Debt to Equity

0.99

Issuance of Debt (TTM)

$401.33M

Repayment of Debt (TTM)

-$4.76M

Key Statistics

Open

$6.44

Close

-

Volume / Avg.

67.00K / 164.47K

Day Range

$6.34 - $6.57

52 Wk Range

6.40 - 30.36

Market Cap

$2.19B

P/E Ratio

275.78

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

0.04%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tom...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Telix Pharmaceuticals (TLX) stock?

A

You can purchase shares of Telix Pharmaceuticals (NASDAQ:TLX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Telix Pharmaceuticals (TLX) competitors?

A

Other companies in Telix Pharmaceuticals’s space includes: Immunome Inc (NASDAQ:IMNM), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Sarepta Therapeutics Inc (NASDAQ:SRPT), Ascentage Pharma Group International (NASDAQ:AAPG) and Syndax Pharmaceuticals Inc (NASDAQ:SNDX).

Q

What is the forecast, or price target, for Telix Pharmaceuticals (TLX) stock?

A

Telix Pharmaceuticals has a consensus price target of $21.20.

Q

What is the current price for Telix Pharmaceuticals (TLX)?

A

The stock price for Telix Pharmaceuticals (NASDAQ: TLX) is $6.53 last updated February 13, 2026 at 10:59 AM EST.

Q

Does Telix Pharmaceuticals (TLX) pay a dividend?

A

There are no upcoming dividends for Telix Pharmaceuticals.

Q

When is Telix Pharmaceuticals (NASDAQ:TLX) reporting earnings?

A

Telix Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Telix Pharmaceuticals (TLX) going to split?

A

There is no upcoming split for Telix Pharmaceuticals.

Q

What sector and industry does Telix Pharmaceuticals (TLX) operate in?

A

Telix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Ultragenyx Pharmaceutical Inc

Sarepta Therapeutics Inc

Ascentage Pharma Group International

Syndax Pharmaceuticals Inc

Tango Therapeutics Inc

Olema Pharmaceuticals inc